Hyul-Tong-Ryung suppresses PMA-induced MMP-9 expression by inhibiting AP-1-mediated gene expression via ERK1/2 signaling pathway in MCF-7 human breast cancer cells

被引:8
作者
Kim, Kyoung-Sook [1 ]
Yao, Lan [1 ,2 ]
Lee, Young-Choon [1 ]
Chung, Eunsook [1 ]
Kim, Kyung-Mi [1 ]
Kwak, Yeon-Joo [1 ]
Kim, Seok-Jo [1 ]
Cui, Zheng [1 ,2 ]
Lee, Jai-Heon [1 ]
机构
[1] Dong A Univ, Coll Nat Resources & Life Sci, Ctr Silver Bio Industrializat BK21, Pusan 604714, South Korea
[2] Shenyang Pharmaceut Univ, Lab China Korea Mol Pharmacognosy, Shenyang, Peoples R China
关键词
AP-1; ERK 1/2 signaling pathway; Hyul-Tong-Ryung; MCF-7; cells; MMP-9; MATRIX METALLOPROTEINASES; MATRIX-METALLOPROTEINASE-9; EXPRESSION; MECHANISM; INVASION;
D O I
10.3109/08923971003610817
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Our previous study has demonstrated that the methanol extract of Hyul-Tong-Ryung (HM) specifically suppresses the phorbol 12-myristate 13-acetate (PMA)-induced matrix metalloproteinase-9 (MMP-9) production through the inhibition of MMP-9 mRNA expression in MCF-7 human breast carcinoma cells. However, the molecular mechanisms involved in transcriptional suppression of MMP-9 by HM in PMA-induced MCF-7 cells are not known. In this study, we aimed to elucidate the molecular mechanisms involved in the inhibition of MMP-9 expression by HM in PMA-induced MCF-7 cells. The results of promoter assay and EMSA showed that HM specifically inhibits MMP-9 gene expression by blocking PMA-stimulated activation of activator protein-1 (AP-1). In addition, PMA-stimulated phosphorylation of extracellular signal regulated kinase1/2 (ERK1/2) was suppressed by HM treatment, whereas the phosphorylation of either c-Jun N-terminal kinase (JNK) or p38 mitogen-activated protein kinase (MAPK) was not affected. HM could inhibit the PMA-induced MMP-9 expression through suppression of the transcriptional activity of MMP-9 gene in MCF-7 cells. These results indicate that HM inhibits PMA-induced MMP-9 expression by blocking the activation of activator protein-1 (AP-1) via extracellular signal regulated kinase1/2 (ERK 1/2) signaling pathway.</.
引用
收藏
页码:600 / 606
页数:7
相关论文
共 11 条
[1]   Gelatinase-mediated migration and invasion of cancer cells [J].
Björklund, M ;
Koivunen, E .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2005, 1755 (01) :37-69
[2]   Inhibitory effect of methanol extract of Euonymus alatus on matrix metalloproteinase-9 [J].
Cha, BY ;
Park, CJ ;
Lee, DG ;
Lee, YC ;
Kim, DW ;
Kim, JD ;
Seo, WG ;
Kim, CH .
JOURNAL OF ETHNOPHARMACOLOGY, 2003, 85 (01) :163-167
[3]   Regulation of matrix metalloproteinases: An overview [J].
Chakraborti, S ;
Mandal, M ;
Das, S ;
Mandal, A ;
Chakraborti, T .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2003, 253 (1-2) :269-285
[4]   Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism [J].
Chung, TW ;
Moon, SK ;
Chang, YC ;
Ko, JH ;
Lee, YC ;
Cho, G ;
Kim, SH ;
Kim, JG ;
Kim, CH .
FASEB JOURNAL, 2004, 18 (14) :1670-1681
[5]   New functions for the matrix metalloproteinases in cancer progression [J].
Egeblad, M ;
Werb, Z .
NATURE REVIEWS CANCER, 2002, 2 (03) :161-174
[6]   Ascochlorin inhibits matrix metalloproteinase-9 expression by suppressing activator protein-1-mediated gene expression through the ERK1/2 signaling pathway - Inhibitory effects of ascochlorin on the invasion of renal carcinoma cells [J].
Hong, S ;
Park, KK ;
Magae, J ;
Ando, K ;
Lee, TS ;
Kwon, TK ;
Kwak, JY ;
Kim, CH ;
Chang, YC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (26) :25202-25209
[7]  
SATO H, 1993, ONCOGENE, V8, P395
[8]   AP-1 in cell proliferation and survival [J].
Shaulian, E ;
Karin, M .
ONCOGENE, 2001, 20 (19) :2390-2400
[9]   Extracellular matrix remodelling: the role of matrix metalloproteinases [J].
Stamenkovic, I .
JOURNAL OF PATHOLOGY, 2003, 200 (04) :448-464
[10]   Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC δ signal transduction [J].
Woo, JH ;
Lim, JH ;
Kim, YH ;
Suh, SI ;
Min, DS ;
Chang, JS ;
Lee, YH ;
Park, JW ;
Kwon, TK .
ONCOGENE, 2004, 23 (10) :1845-1853